Astral Ltd approves composite scheme of arrangement
Astral Ltd filed a Regulation 30 notice on 25 June 2026 confirming approval of its composite scheme of arrangement.
What Astral Ltd announced
Astral Ltd submitted a Regulation 30 filing with the Bombay Stock Exchange on 25 June 2026, indicating that its composite scheme of arrangement has been approved by the requisite authorities. The notice, filed under the Listing Obligations and Disclosure Requirements (LODR), serves as a formal communication to shareholders and the market that the restructuring plan is moving forward.
"Regulation 30 Approval of Composite scheme of Arrangement" – Astral Ltd, 25 June 2026.
The filing does not provide details on the financial terms, the specific assets or liabilities involved, or the expected impact on the company’s capital structure.
Composite scheme of arrangement – basics
A composite scheme of arrangement is a court‑sanctioned restructuring tool that can combine multiple types of transactions—such as mergers, demergers, amalgamations, or capital restructuring—into a single scheme. Under Section 230 of the Companies Act, 2013, the scheme must be approved by a majority in value of the shareholders and by the National Company Law Tribunal (NCLT).
Astral’s filing confirms that the scheme has cleared the initial regulatory hurdle (approval under the Companies Act) and is now awaiting any further procedural steps, such as shareholder meetings and NCLT sanction.
Key facts at a glance
| Detail | Value |
|---|---|
| Company | Astral Ltd |
| BSE Scrip Code | 532830 |
| Filing date | 25 June 2026 (13:40:20 UTC) |
| Regulation | 30 (LODR) – Restructuring |
| Announcement type | Approval of composite scheme of arrangement |
| Financial terms disclosed | None in the filing |
| Next regulatory step | Shareholder approval & NCLT sanction |
Why this matters for investors
The approval of a composite scheme signals that Astral is pursuing a structured restructuring, which could affect its operational focus, asset base, or capital structure. While the filing does not disclose the quantitative impact, investors should monitor subsequent disclosures—especially shareholder meeting results and NCLT orders—to understand any potential dilution, asset transfers, or changes in control.
Conclusion
Astral Ltd’s Regulation 30 filing on 25 June 2026 confirms that its composite scheme of arrangement has received the required regulatory approval. The next steps involve shareholder voting and NCLT endorsement before the restructuring can be executed. Investors should await further updates for detailed financial implications.
Frequently asked questions
Related stocks
Source filing: view original